Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Dare Bioscience, Inc. | dare-ex321_435.htm |
EX-31.2 - EX-31.2 - Dare Bioscience, Inc. | dare-ex312_436.htm |
EX-31.1 - EX-31.1 - Dare Bioscience, Inc. | dare-ex311_437.htm |
EX-23.1 - EX-23.1 - Dare Bioscience, Inc. | dare-ex231_429.htm |
EX-21.1 - EX-21.1 - Dare Bioscience, Inc. | dare-ex211_430.htm |
EX-10.14(B) - EX-10.14(B) - Dare Bioscience, Inc. | dare-ex1014b_438.htm |
EX-10.14(A) - EX-10.14(A) - Dare Bioscience, Inc. | dare-ex1014a_431.htm |
EX-10.1 - EX-10.1 - Dare Bioscience, Inc. | dare-ex101_432.htm |
EX-4.1 - EX-4.1 - Dare Bioscience, Inc. | dare-ex41_433.htm |
10-K - 10-K - Dare Bioscience, Inc. | dare-10k_20171231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Daré Bioscience, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2017 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 28, 2018 /s/ Lisa Walters-Hoffert
Lisa Walters-Hoffert
Chief Financial Officer
(principal financial officer and principal accounting officer)